Skip to content

Efficacy of Mindfulness Based Cognitive Therapy for patients with Obsessive Compulsive Disorder

Efficacy of Mindfulness Based Cognitive Therapy for patients with Obsessive Compulsive Disorder

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004525
Enrollment
128
Registered
2013-03-19
Start date
2014-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F42

Interventions

Group 1: Mindfulness Based Cognitive Therapy, 8 weekly sessions (120 minutes) in an outpatient group setting Group 2: OCD education program, 8 weekly sessions (120 minutes) in an outpatient group sett

Sponsors

Universitätsklinik für Psychiatrie und Psychosomatik Abteilung Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: written informed consent age 18-70 primary diagnosis of OCD (ICD-10 F42.-) at least 20 sessions of CBT with ERP within 3 years prior to study inclusion clinically relevant OCD, i.e. Y-BOCS global score > 12 at study inclusion fulfilled DSM-IV criteria for OCD for a period of = three years prior to study inclusion, either without an aymptomatic period or an asymptomatic period of < 6 months

Exclusion criteria

Exclusion criteria: begun or altered medication within 12 weeks before study inclusion receiving benzodiazepines mania (ICD-10 F30.-) suicidal tendency current severe depressive episode (BDI>28) borderline disorder (ICD-10 F60.3) current substance abuse or substance dependence (ICD-10 F1x.2) intelligence quotient < 70 psychosis (ICD-10 F20-F29) severe neurological disorder indication of Asperger syndrome (ICD-10 F84.5)

Design outcomes

Primary

MeasureTime frame
the severity of obsessive compulsive symptoms as measured by the Yale Brown Obsessive Compulsive Scale, an established and very commonly used semi-structured interview. Assesment time points are pre, post and 6- and 12-months-follow-ups

Secondary

MeasureTime frame
- depression (Beck Depression Inventory) - global level of psychopathology (Brief Symptom Inventory) - quality of life (World Health Organization Quality of Life abbreviated) - mindfulness (Kentucky Inventory of Mindfulness Skills) - metacognitions (Obsessive Belief Questionnaire, Metacognitions Questionnaire) - psychological flexibility/experiential avoidance (Acceptance and Action Questionnaire) Assesment time points are pre, post and 6- and 12-months-follow-ups

Countries

Germany

Contacts

Public ContactSarah Landmann

Universitätsklinikum Freiburg, Abteilung für Psychiatrie und Psychotherapie

sarah.landmann@uniklinik-freiburg.de0049 761 270 69770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 19, 2026